The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Comprehensive Expression Profiling of Tumor Cell Lines Identifies Molecular Signatures of Melanoma Progression
Open accessAbstract
BACKGROUND: Gene expression profiling has revolutionized our ability to molecularly classify primary human tumors and significantly enhanced the development of novel tumor markers and therapies; however, progress in the diagnosis and treatment of melanoma over the past 3 decades has been limited, and there is currently no approved therapy that significantly extends lifespan in patients with advanced disease. Profiling studies of melanoma to date have been inconsistent due to the heterogeneous nature of this malignancy and the limited availability of informative tissue specimens from early stages of disease. METHODOLOGY/PRINCIPLE FINDINGS: In order to gain an improved understanding of the molecular basis of melanoma progression, we have compared gene expression profiles from a series of melanoma cell lines representing discrete stages of malignant progression that recapitulate critical characteristics of the primary lesions from which they were derived. Here we describe the unsupervised hierarchical clustering of profiling data from melanoma cell lines and melanocytes. This clustering identifies two distinctive molecular subclasses of melanoma segregating aggressive metastatic tumor cell lines from less-aggressive primary tumor cell lines. Further analysis of expression signatures associated with melanoma progression using functional annotations categorized these transcripts into three classes of genes: 1) Upregulation of activators of cell cycle progression, DNA replication and repair (CDCA2, NCAPH, NCAPG, NCAPG2, PBK, NUSAP1, BIRC5, ESCO2, HELLS, MELK, GINS1, GINS4, RAD54L, TYMS, and DHFR), 2) Loss of genes associated with cellular adhesion and melanocyte differentiation (CDH3, CDH1, c-KIT, PAX3, CITED1/MSG-1, TYR, MELANA, MC1R, and OCA2), 3) Upregulation of genes associated with resistance to apoptosis (BIRC5/survivin). While these broad classes of transcripts have previously been implicated in the progression of melanoma and other malignancies, the specific genes identified within each class of transcripts are novel. In addition, the transcription factor NF-KB was specifically identified as being a potential "master regulator" of melanoma invasion since NF-KB binding sites were identified as consistent consensus sequences within promoters of progression-associated genes. CONCLUSIONS/SIGNIFICANCE: We conclude that tumor cell lines are a valuable resource for the early identification of gene signatures associated with malignant progression in tumors with significant heterogeneity like melanoma. We further conclude that the development of novel data reduction algorithms for analysis of microarray studies is critical to allow for optimized mining of important, clinically-relevant datasets. It is expected that subsequent validation studies in primary human tissues using such an approach will lead to more rapid translation of such studies to the identification of novel tumor biomarkers and therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,314
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Open source clustering software
de Hoon, M. J. L., Imoto, S., Nolan, J., & Miyano, S. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth078 · Cited by 3,043
Molecular classification of cutaneous malignant melanoma by gene expression profiling
Bittner, M., Meltzer, P., Chen, Y., Jiang, Y., Seftor, E., Hendrix, M., Radmacher, M., Simon, R., Yakhini, Z., Ben-Dor, A., et al. (2000) · Nature · doi:10.1038/35020115 · Cited by 1,990
Control of apoptosis and mitotic spindle checkpoint by survivin
Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C., & Altieri, D. C. (1998) · Nature · doi:10.1038/25141 · Cited by 1,870
Ohoka, N., Yoshii, S., Hattori, T., Onozaki, K., & Hayashi, H. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600596 · Cited by 1,016
A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma
Clark, W. H., Elder, D. E., Guerry, D., Epstein, M. N., Greene, M. H., & Van Horn, M. (1984) · Human Pathology · doi:10.1016/s0046-8177(84)80310-x · Cited by 975
Ono, T., Losada, A., Hirano, M., Myers, M. P., Neuwald, A. F., & Hirano, T. (2003) · Cell · doi:10.1016/s0092-8674(03)00724-4 · Cited by 550
Hirano, T., Kobayashi, R., & Hirano, M. (1997) · Cell · doi:10.1016/s0092-8674(00)80233-0 · Cited by 540
Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome
Winnepenninckx, V., Lazar, V., Michiels, S., Dessen, P., Stas, M., Alonso, S. R., Avril, M.-F., Ortiz Romero, P. L., Robert, T., Balacescu, O., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj103 · Cited by 480
Microarray Analysis and Tumor Classification
Quackenbush, J. (2006) · New England Journal of Medicine · doi:10.1056/nejmra042342 · Cited by 455
Expression Profiling Reveals Novel Pathways in the Transformation of Melanocytes to Melanomas
Hoek, K., Rimm, D. L., Williams, K. R., Zhao, H., Ariyan, S., Lin, A., Kluger, H. M., Berger, A. J., Cheng, E., Trombetta, E. S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0731 · Cited by 448
The gene expression signatures of melanoma progression
Haqq, C., Nosrati, M., Sudilovsky, D., Crothers, J., Khodabakhsh, D., Pulliam, B. L., Federman, S., Miller, J. R., Allen, R. E., Singer, M. I., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501564102 · Cited by 433
Expression profiling reveals novel pathways in the transformation of Melanocytes to Melanomas.
Hoek, K., Rimm, D., Williams, K., Zhao, H., Ariyan, S., Lin, A., Kluger, H., Berger, A., Cheng, E., Trombetta, E. S., et al. (2004) · Pigment Cell Research · doi:10.1111/j.1600-0749.2004.00175_12.x · Cited by 412
Vega, H., Waisfisz, Q., Gordillo, M., Sakai, N., Yanagihara, I., Yamada, M., van Gosliga, D., Kayserili, H., Xu, C., Ozono, K., et al. (2005) · Nature Genetics · doi:10.1038/ng1548 · Cited by 378
Suzuki, I. (1996) · Endocrinology · doi:10.1210/en.137.5.1627 · Cited by 333
Mackenzie, M. A. F., Jordan, S. A., Budd, P. S., & Jackson, I. J. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8738 · Cited by 331
Du, J., Miller, A. J., Widlund, H. R., Horstmann, M. A., Ramaswamy, S., & Fisher, D. E. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63657-7 · Cited by 313
Characteristics of cultured human melanocytes isolated from different stages of tumor progression.
Herlyn, M., Thurin, J., Balaban, G. B., Bennicelli, J. L., Herlyn, D., Elder, D. E., Bondi, E. E., Guerry, D., Nowell̀, P. C., & Clark, W. H. (1985) · PubMed · Cited by 274
Obuse, C., Iwasaki, O., Kiyomitsu, T., Goshima, G., Toyoda, Y., & Yanagida, M. (2004) · Nature Cell Biology · doi:10.1038/ncb1187 · Cited by 258
Repo-Man recruits PP1γ to chromatin and is essential for cell viability
Trinkle-Mulcahy, L., Andersen, J., Lam, Y. W., Moorhead, G., Mann, M., & Lamond, A. I. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200508154 · Cited by 257
NuSAP, a novel microtubule-associated protein involved in mitotic spindle organization
Raemaekers, T., Ribbeck, K., Beaudouin, J., Annaert, W., Van Camp, M., Stockmans, I., Smets, N., Bouillon, R., Ellenberg, J., & Carmeliet, G. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302129 · Cited by 247
Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase
Banerjee, D., Mayer-Kuckuk, P., Capiaux, G., Budak-Alpdogan, T., Gorlick, R., & Bertino, J. R. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00079-0 · Cited by 242
Jaeger, J., Koczan, D., Thiesen, H.-J., Ibrahim, S. M., Gross, G., Spang, R., & Kunz, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1820 · Cited by 233
Rofstad, E. K., & Halsør, E. F. (2000) · PubMed · Cited by 229
Human Melanoma Progression in Skin Reconstructs
Meier, F., Nesbit, M., Hsu, M.-Y., Martin, B., Van Belle, P., Elder, D. E., Schaumburg-Lever, G., Garbe, C., Walz, T. M., Donatien, P., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64719-0 · Cited by 225
Drug Resistance in Melanoma: Mechanisms, Apoptosis, and New Potential Therapeutic Targets
Grossman, D., & Altieri, D. C. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1013123532723 · Cited by 218
Hsu, M.-Y., Shih, D.-T., Meier, F. E., Van Belle, P., Hsu, J.-Y., Elder, D. E., Buck, C. A., & Herlyn, M. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65730-6 · Cited by 208
Sun, L.-Q., Lee, D. W., Zhang, Q., Xiao, W., Raabe, E. H., Meeker, A., Miao, D., Huso, D. L., & Arceci, R. J. (2004) · Genes & Development · doi:10.1101/gad.1176104 · Cited by 186
Chromosome Condensation by a Human Condensin Complex inXenopus Egg Extracts
Kimura, K., Cuvier, O., & Hirano, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000873200 · Cited by 178
Epigenetic Silencing of Novel Tumor Suppressors in Malignant Melanoma
Muthusamy, V., Duraisamy, S., Bradbury, C. M., Hobbs, C., Curley, D. P., Nelson, B., & Bosenberg, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1274 · Cited by 172
Wesley, U. V., McGroarty, M., & Homoyouni, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1852 · Cited by 166
Ueda, Y., & Richmond, A. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00304.x · Cited by 163
Transcription factors in melanocyte development: distinct roles for Pax-3 and Mitf
Hornyak, T. J., Hayes, D. J., Chiu, L.-Y., & Ziff, E. B. (2001) · Mechanisms of Development · doi:10.1016/s0925-4773(00)00569-4 · Cited by 160
Melanoma cell lines from different stages of progression and their biological and molecular analyses
Satyamoorthy, K., Dejesus, E., Linnenbach, A. J., Kraj, B., Kornreich, D. L., Rendle, S., Elder, D. E., & Herlyn, M. (1997) · Melanoma Research · doi:10.1097/00008390-199708001-00007 · Cited by 149
Cadherins in neural crest cell development and transformation
Pla, P., Moore, R. H., Morali, O. G., Julien-Grille, S., Martinozzi, S., Delmas, V., & Larue, L. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.10008 · Cited by 142
Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development.
Zindy, F., Soares, H. D., Herzog, K., Morgan, J., Sherr, C. J., & Roussel, M. F. (1997) · PubMed · Cited by 140
Molecular genetics of oculocutaneous albinism
Spritz, R. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.suppl_1.1469 · Cited by 134
The Syk tyrosine kinase: A new negative regulator in tumor growth and progression
Coopman, P. J., & Mueller, S. C. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.11.004 · Cited by 133
Regulation of E- and P-Cadherin Expression Correlated with Melanocyte Migration and Diversification
Nishimura, E. K., Yoshida, H., Kunisada, T., & Nishikawa, S. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9478 · Cited by 121
Substrate Specificity and Activity Regulation of Protein Kinase MELK
Beullens, M., Vancauwenbergh, S., MORRICE, N. A., Derua, R., Ceulemans, H., Waelkens, E., & Bollen, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507274200 · Cited by 111
Simons-Evelyn, M., Bailey-Dell, K., Toretsky, J. A., Ross, D. D., Fenton, R. G., Kalvakolanu, D. V., & Rapoport, A. P. (2001) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2001.0452 · Cited by 109
PSF1 Is Essential for Early Embryogenesis in Mice
Ueno, M., Itoh, M., Kong, L., Sugihara, K., Asano, M., & Takakura, N. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.23.10528-10532.2005 · Cited by 82
Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome
Weeraratna, A. T., Becker, D., Carr, K. M., Duray, P. H., Rosenblatt, K. P., Yang, S. W., Chen, Y., Bittner, M. L., Strausberg, R. L., Riggins, G. J., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207337 · Cited by 72
The role of cadherin/catenin complex in malignant melanoma.
Bonitsis, N. G., Batistatou, A. K., Karantima, S., & Charalabopoulos, K. (2006) · PubMed · Cited by 56
Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas.
Vachtenheim, J., & Novotná, H. (1999) · PubMed · Cited by 46
A Web-Based Data Warehouse on Gene Expression in Human Malignant Melanoma
Győrffy, B., & Lage, H. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700543 · Cited by 44
Smith, A. P., Weeraratna, A. T., Spears, J. R., Meltzer, P. S., & Becker, D. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.1.661 · Cited by 22
Identification and characterization of mouse PSF1-binding protein, SLD5
Kong, L., Ueno, M., Itoh, M., Yoshioka, K., & Takakura, N. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.136 · Cited by 15
Cited by
Machine Learning Methods in Drug Discovery
Patel, L., Shukla, T., Huang, X., Ussery, D. W., & Wang, S. (2020) · Molecules · doi:10.3390/molecules25225277 · Cited by 460
The histone variant macroH2A suppresses melanoma progression through regulation of CDK8
Kapoor, A., Goldberg, M. S., Cumberland, L. K., Ratnakumar, K., Segura, M. F., Emanuel, P. O., Menendez, S., Vardabasso, C., LeRoy, G., Vidal, C. I., et al. (2010) · Nature · doi:10.1038/nature09590 · Cited by 397
Chien, A. J., Moore, E. C., Lonsdorf, A. S., Kulikauskas, R. M., Rothberg, B. G., Berger, A. J., Major, M. B., Hwang, S. T., Rimm, D. L., & Moon, R. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811902106 · Cited by 332
Jiang, Y., Mao, C., Yang, R., Yan, B., Shi, Y., Liu, X., Lai, W., Liu, Y., Wang, X., Xiao, D., et al. (2017) · Theranostics · doi:10.7150/thno.19988 · Cited by 292
Novel MITF targets identified using a two‐step DNA microarray strategy
Hoek, K. S., Schlegel, N. C., Eichhoff, O. M., Widmer, D. S., Praetorius, C., Einarsson, S. O., Valgeirsdottir, S., Bergsteinsdottir, K., Schepsky, A., Dummer, R., et al. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2008.00505.x · Cited by 262
Metadata
- Authors
- Ryu, B., Kim, D. S., DeLuca, A. M., & Alani, R. M.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-07-04
- Volume
- 2
- Issue
- 7
- Pages
- e594
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2017806952
- Cited by
- 289
- References
- 51
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.